Heartland Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3M Buy
1,058,311
+908,311
+606% +$13M 0.55% 59
2026
Q1
$2.52M Buy
+150,000
New +$2.68M 0.13% 195

Other funds holding CLB

Heartland Advisors's CLB Position: Q2 2026 in Review

Heartland Advisors increased its Core Laboratories (CLB) stake by 606% in Q2 2026, buying an estimated $13M and bringing the position to 1,058,311 shares worth $12.3M. The position accounts for 0.55% of the portfolio, ranked #59.

Heartland Advisors first reported a position in CLB in Q1 2026 and has held it in 2 quarters since. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Heartland Advisors held 1,058,311 shares of Core Laboratories worth $12.3M as of Q2 2026.
  • Heartland Advisors bought 908,311 Core Laboratories shares in Q2 2026, an estimated $13M.
  • Core Laboratories made up 0.55% of Heartland Advisors's portfolio in Q2 2026, its #59 holding.
  • Heartland Advisors first reported a position in Core Laboratories in Q1 2026 and has held it in 2 quarters since.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Heartland Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.